SML3047

Urolithin C

≥97% (HPLC), Insulin secretion activator, powder

• Synonym(e): 3,8,9-Trihydroxy-6H-benzo[c]chromen-6-one, 3,8,9-Trihydroxy-6H-dibenzo[b,d]pyran-6-one, 3,8,9-Trihydroxyurolithin
• Empirische Formel (Hill-System): C₁₃H₈O₅
• CAS-Nummer: 165393-06-6
• Molekulargewicht: 244.20
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD20275232
• Assay: ≥97% (HPLC)
• Form: powder

Eigenschaften

• Produktname: Urolithin C, ≥97% (HPLC)
• Quality Segment: 100
• assay: ≥97% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: −20°C
• SMILES string: O=C1C2=CC(O)=C(O)C=C2C3=C(C=C(O)C=C3)O1
• InChI key: HHXMEXZVPJFAIJ-UHFFFAOYSA-N

Beschreibung

Biochem/physiol Actions

Urolithin C is chebulic ellagitannins metabolite that exerts antiproliferative and antioxidant activity. Urolithin C exhibit glucose dependent enhancement of insulin secretion in islet cells under normal or dysfunctional conditions. Apparently, it facilitates L-type Ca²⁺ channel opening and Ca²⁺ influx into pancreatic β-cells.

chebulic ellagitannins metabolite, exhibit glucose dependent enhancement of insulin secretion

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable